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Myxoma virus (MYXV; family Poxviridae, subfamily 
Chordopoxvirinae, genus Leporipoxvirus)1 is a linear double-
stranded DNA virus that specifically infects rabbits and 
hares. If introduced in European rabbits (Oryctolagus cunic-
ulus), the virus causes the mostly fatal disease myxomatosis, 
named after the prominent mucinous skin lesions.3 Affected 
rabbits display conjunctivitis, anorexia, listlessness, and fever. 
Animals may die within 2 days after onset of symptoms. In a 
more prolonged disease course, depression and myxomas in 
the eyelids, nose, lips, ears, vulva, or scrotum are observed. 
The edematous ears become heavy and droop. Animals usu-
ally die within 1–2 weeks due to emaciation and dyspnea.4 In 
the course of an outbreak, the virulence is reduced,6 and the 
disease is characterized by reduced mortality in young animals 
and seropositivity of all adult rabbits.2 The European rabbit is 
highly susceptible, a fact that has been exploited in the deliber-
ate release of MYXV strain Moses in Australia (1950) and 
strain Lausanne in Europe (1952) to control feral rabbits.5,10 
Both strains were originally isolated in Brazil.4,10 Contrary to 
the fatal disease in European rabbits, MYXV only produces 
local fibromas in its natural host, the wild American cottontail 
rabbits (Sylvilagus spp.).3,10 As seen in the Australian out-
break in 1950, the virus is efficiently transmitted over large 
distances by blood-sucking vectors, such as mosquitoes and 
rabbit fleas (Spilopsyllus cuniculi).5
In Switzerland, myxomatosis is a notifiable disease, and 
vaccination is strictly forbidden.11 A total of 68 cases were 
reported to the Swiss Federal Veterinary Office from 1991 to 
2010 (http://www.infosm.bvet.admin.ch; date of accession 
March 7, 2011). The diagnosis of myxomatosis is based on 
clinical presentation of typical symptoms and histology. In 
order to have a faster diagnostic tool, a quantitative real-time 
PCR (qPCR) was developed and validated, as described in 
the current study.
Primers for the MYXV qPCR were designed with the 
Primer3 program9 to amplify a 147-bp fragment within the 
serpin (Serp2) gene (accession no. U60474).8 Viral DNA was 
extracted from all viral strains, swabs, and fresh and paraffin-
embedded tissues samples using a commercial kita following 
the manufacturer’s protocols. In addition, after lysis of fresh 
and paraffin-embedded tissue, a homogenizer columnb was 
used. Quantitative PCR assays were performed on a thermo-
cyclerc with the standard cycle protocol of 2 min at 50°C, 10 
min at 95°C, followed by 40 cycles of denaturation at 95°C 
for 15 sec and annealing at 60°C for 1 min. The MYXV PCR was 
carried out in 25-µl reactions containing (final concentrations) 
12.5 µl of commercial PCR reaction mixture,d 900 nM of each 
primer (Serp2_For: 5’-GTCGGACGTCTTCGTTTCTC-3’; 
Serp2_Rev: 5’-ACTCTGGATGCGACGGTTAC-3’),e 250 nM 
of probe Serp2_Probe (5’-FAM-CGCGCAATTACGTCTC 
GCCC-TAMRA-3’),e and 7 µl of extracted DNA.
Analytical sensitivity was determined using the standard 
curve approach. An oligo with a length of 147 bp correspond-
ing to the amplicon size was synthesizede and designated 
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Abstract. To aid in the rapid diagnosis of myxomatosis in rabbits, a real-time polymerase chain reaction (PCR) for 
the specific detection of Myxoma virus is described. Primers and probe were designed to amplify a 147-bp fragment within 
the Serp2 gene. The assay was able to detect 23 copies of a synthesized oligo indicating a reliable sensitivity. In addition, the 
real-time PCR did not detect the Rabbit fibroma virus used in myxomatosis vaccines. The novel PCR was shown to be able to 
detect Myxoma virus in fresh and paraffin-embedded rabbit tissues originating from myxomatosis cases from various regions 
in Switzerland.
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Serp2_Oligo. For analytical specificity, the following virus 
strains of the genus Leporipoxvirus were used: MYXV strain 
Munich 1,f MYXV isolate Hasi 1998,g and Rabbit fibroma 
virus contained in a myxomatosis vaccine.h Furthermore, the 
Rabbitpox virus strain CAM.-klon.2/87f was tested. In addi-
tion, Pasteurella multocida subsp. multocidai and Bordetella 
bronchisepticai were tested.
The PCR was tested on paraffin-embedded organ samples 
from farm, pet, and wild rabbits as well as fresh swab and tis-
sue samples of 4 rabbitsj (Table 1). Further, nasal swabs from 
healthy Swiss pedigree rabbits of 3 Swiss breeds (Schweizer 
Fuchs, Schweizer Dreifarben-Kleinschecke, and Schweizer 
Feh) were taken.k The animals originated from 3 different 
regions in Switzerland and had not been vaccinated. A total of 
12 rabbits from each region (comprised of 3 rabbits of each 
breed) were tested with the new myxomatosis qPCR.
The analytical sensitivity of the MYXV qPCR was deter-
mined using 10-fold dilution series of the Serp2_Oligo. The 
assay was able to detect 230 copies in 100% and 23 copies 
in 60% of experiments. Linearity persisted over a range of 
107–103 copies. The coefficient of determination for the linear 
regression was 0.9977 (data not shown). The MYXV qPCR 
was able to detect the 2 MYXV strains tested, while no signal 
was produced with Rabbit fibroma virus or with Rabbitpox 
virus. Pasteurella multocida subsp. multocida and B. bron-
chiseptica were negative.
Swiss field cases of myxomatosis in farm and pet rabbits, 
as well as in 1 wild rabbit, occurring throughout the country 
within the last decade were used to test the qPCR in a diagnos-
tic procedure. All of these cases had been confirmed by histol-
ogy, and all tested positive by qPCR. Three suspicious cases, 
which were negative in histology, also proved negative by 
qPCR (Table 1). As well, 36 selected nasal swabs of pedigree 
rabbits were subjected to the MYXV qPCR, and all of them 
tested negative (Table 1).
The current study shows that the qPCR is able to detect 
myxomatosis cases in farm, pet, and wild rabbits using 
swabs and fresh or paraffin-embedded tissues from the last 
10 years. Although myxomatosis is infrequently diagnosed 
in Switzerland (68 cases from 1991 to 2010), spillover from 
wild rabbit populations and importation of rabbits can pro-
voke new outbreaks.11 The qPCR developed in the present 
study simplifies the diagnosis of myxomatosis in clinical 
cases as well as from fresh or paraffin-embedded tissue sam-
ples. Suspicious cases can be quickly affirmed by taking a 
nasal, ocular, or genital swab. This is also important in the 
chronic form of myxomatosis, which may not present typical 
lesions and may be inconclusive in histology.7,11 Furthermore, 
protective measures for flocks in the vicinity of a disease 
outbreak can be implemented very quickly, such as insect 
control to prevent spreading by vectors and restriction of ani-
mal movements. As the test works well in paraffin-embedded 
tissue, myxomatosis can also be diagnosed retrospectively 
from archived samples. Thus, the newly developed assay will 
be helpful in generating a fast diagnosis for a notifiable 
disease.
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Table 1. Real-time Myxoma virus polymerase chain reaction (PCR) assessment of swabs and fresh and paraffin-embedded tissue 
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Year Animal
No. of 
animals
Clinical 
presentation Samples for PCR test*
No. of animals 
PCR positive†
Histology 
positive
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eyelid, nasal mucosa, liver, spleen, 
mediastinal lymph node, vulva
1/1 1/1
* Skin and submucosa were taken from the typical myxoma lesions on the head.
† If positive, all samples of each animal were positive.
‡ Samples from the Laboratoire Galli Valerio, Lausanne, Switzerland.
§ Rabbit had recently been on holiday abroad.
¦ ND = not done.
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